M&R Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $92K | Buy |
852
+105
| +14% | +$11.5K | 0.02% | 191 |
|
|
2024
Q2 | $81.1K | Hold |
747
| – | – | 0.02% | 193 |
|
|
2024
Q1 | $98.8K | Hold |
747
| – | – | 0.02% | 178 |
|
|
2023
Q4 | $90.9K | Hold |
747
| – | – | 0.02% | 206 |
|
|
2023
Q3 | $83.8K | Hold |
747
| – | – | 0.02% | 202 |
|
|
2023
Q2 | $109K | Hold |
747
| – | – | 0.03% | 178 |
|
|
2023
Q1 | $96.5K | Hold |
747
| – | – | 0.03% | 186 |
|
|
2022
Q4 | $95.2K | Hold |
747
| – | – | 0.03% | 192 |
|
|
2022
Q3 | $78K | Hold |
747
| – | – | 0.02% | 200 |
|
|
2022
Q2 | $78K | Buy |
747
+20
| +3% | +$2.37K | 0.02% | 204 |
|
|
2022
Q1 | $92K | Buy |
727
+490
| +207% | +$59.1K | 0.02% | 198 |
|
|
2021
Q4 | $29K | Hold |
237
| – | – | 0.01% | 270 |
|
|
2021
Q3 | $33K | Hold |
237
| – | – | 0.01% | 256 |
|
|
2021
Q2 | $36K | Buy |
237
+99
| +72% | +$16K | 0.01% | 263 |
|
|
2021
Q1 | $21K | Hold |
138
| – | – | 0.01% | 285 |
|
|
2020
Q4 | $20K | Sell |
138
-86
| -38% | -$12.1K | ﹤0.01% | 305 |
|
|
2020
Q3 | $29K | Sell |
224
-2
| -0.9% | -$261 | 0.01% | 285 |
|
|
2020
Q2 | $26K | Sell |
226
-846
| -79% | -$97.5K | 0.01% | 289 |
|
|
2020
Q1 | $105K | Hold |
1,072
| – | – | 0.03% | 192 |
|
|
2019
Q4 | $155K | Sell |
1,072
-536
| -33% | -$74K | 0.03% | 188 |
|
|
2019
Q3 | $214K | Hold |
1,608
| – | – | 0.05% | 171 |
|
|
2019
Q2 | $183K | Sell |
1,608
-31
| -2% | -$3.63K | 0.04% | 181 |
|
|
2019
Q1 | $197K | Sell |
1,639
-103
| -6% | -$11.7K | 0.04% | 173 |
|
|
2018
Q4 | $175K | Sell |
1,742
-69
| -4% | -$7.76K | 0.05% | 172 |
|
|
2018
Q3 | $231K | Hold |
1,811
| – | – | 0.05% | 171 |
|
|
2018
Q2 | $195K | Buy |
1,811
+156
| +9% | +$17K | 0.04% | 180 |
|
|
2018
Q1 | $175K | Sell |
1,655
-103
| -6% | -$12K | 0.04% | 192 |
|
|
2017
Q4 | $205K | Buy |
1,758
+51
| +3% | +$5.77K | 0.05% | 178 |
|
|
2017
Q3 | $194K | Sell |
1,707
-515
| -23% | -$59.4K | 0.05% | 185 |
|
|
2017
Q2 | $240K | Hold |
2,222
| – | – | 0.06% | 171 |
|
|
2017
Q1 | $263K | Sell |
2,222
-18
| -0.8% | -$2.04K | 0.07% | 158 |
|
|
2016
Q4 | $224K | Buy |
2,240
+329
| +17% | +$35.3K | 0.06% | 169 |
|
|
2016
Q3 | $241K | Hold |
1,911
| – | – | 0.07% | 156 |
|
|
2016
Q2 | $223K | Buy |
+1,911
| New | +$216K | 0.07% | 157 |
|
|
2014
Q2 | – | Sell |
-12,965
| Closed | -$1.19M | – | 211 |
|
|
2014
Q1 | $1.19M | Sell |
12,965
-154
| -1% | -$14.2K | 0.29% | 73 |
|
|
2013
Q4 | $1.19K | Sell |
13,119
-103
| -0.8% | -$8.91K | 0.31% | 67 |
|
|
2013
Q3 | $1.05M | Hold |
13,222
| – | – | 0.3% | 70 |
|
|
2013
Q2 | $962K | Buy |
+13,222
| New | +$989K | 0.28% | 73 |
|
Other funds holding ZBH
M&R Capital Management's ZBH Position: Q3 2024 in Review
M&R Capital Management increased its Zimmer Biomet (ZBH) stake by 14% in Q3 2024, buying an estimated $11.5K and bringing the position to 852 shares worth $92K. The position accounts for 0.02% of the portfolio, ranked #191.
M&R Capital Management first reported a position in ZBH in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.19M in Q1 2014. 983 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.
- M&R Capital Management held 852 shares of Zimmer Biomet worth $92K as of Q3 2024.
- M&R Capital Management bought 105 Zimmer Biomet shares in Q3 2024, an estimated $11.5K.
- Zimmer Biomet made up 0.02% of M&R Capital Management's portfolio in Q3 2024, its #191 holding.
- M&R Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 38 quarters since.
- M&R Capital Management's Zimmer Biomet position peaked at $1.19M in Q1 2014.
- 983 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.
Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.